LianBio News - LIAN

Company Name	Stock Ticker Symbol	Market	Type
LianBio	LIAN	NASDAQ	Depository Receipt

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.00%	0.319	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				0.319

more quote information »

Recent News

Date	Time	Source	Heading
3/11/2024	07:51	EDGAR2	Form 25 - Notification of the removal from listing and..
2/28/2024	07:00	GLOBE	LianBio Announces Voluntarily Delisting from Nasdaq
2/20/2024	16:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/13/2024	07:04	EDGAR2	Form 8-K - Current report
2/13/2024	07:00	GLOBE	LianBio Announces Completion of Strategic Review
1/08/2024	06:13	EDGAR2	Form 144 - Report of proposed sale of securities
12/29/2023	07:56	EDGAR2	Form 144 - Report of proposed sale of securities
12/26/2023	16:10	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
12/26/2023	16:07	EDGAR2	Form 8-K - Current report
12/26/2023	14:40	APS	Biotech Finds Success Following Holiday Weekend
12/26/2023	02:00	GLOBE	LianBio Enters into Agreement Assigning its Rights for..
12/20/2023	08:05	EDGAR2	Form 8-K - Current report
12/20/2023	08:00	GLOBE	LianBio Announces Departure of Chief Financial Officer
12/19/2023	16:26	EDGAR2	Form 8-K - Current report
12/19/2023	16:05	GLOBE	LianBio Announces Departure of Chief Executive Officer
12/06/2023	16:23	EDGAR2	Form 8-K - Current report
12/06/2023	16:05	GLOBE	LianBio’s Board of Directors Unanimously Determines not to..
12/01/2023	16:16	EDGAR2	Form 8-K - Current report
12/01/2023	16:05	GLOBE	LianBio Confirms Receipt of Unsolicited Proposal from..
11/13/2023	16:28	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	16:17	EDGAR2	Form 8-K - Current report
11/13/2023	16:05	GLOBE	LianBio Reports Third Quarter 2023 Financial Results and..
10/30/2023	16:16	EDGAR2	Form 8-K - Current report
10/30/2023	16:05	GLOBE	LianBio Announces Topline Results from Phase 3 LIBRA Trial..
10/25/2023	16:05	GLOBE	LianBio Announces Presentation of Data from Phase 2a Study..
10/24/2023	10:25	APS	Biotech Shares Soar Premarket
10/24/2023	09:22	DJN	LianBio Shares Soar Premarket on Strategic Review, End of..
10/24/2023	06:59	GLOBE	LianBio Enters into Agreement with Bristol Myers Squibb for..
8/28/2023	16:05	GLOBE	LianBio Announces Results from Phase 3 EXPLORER-CN Trial of..
8/14/2023	16:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:11	EDGAR2	Form 8-K - Current report
8/14/2023	16:05	GLOBE	LianBio Reports Second Quarter 2023 Financial Results and..
8/03/2023	16:05	GLOBE	LianBio Announces First Patient Treated in Phase 1 Trial of..
7/26/2023	08:30	GLOBE	LianBio Partner Tarsus Pharmaceuticals Announces U.S. FDA..
7/18/2023	08:00	GLOBE	LianBio Partner NANOBIOTIX Enters into License Agreement..
7/17/2023	06:00	GLOBE	LianBio Announces Phase 3 EXPLORER-CN Data Accepted for..
7/12/2023	08:00	GLOBE	LianBio Announces Clinical Supply Agreement with AstraZeneca..
6/26/2023	08:00	GLOBE	LianBio Announces Marketing Approval of CAMZYOS®..
6/08/2023	07:00	GLOBE	LianBio Completes Enrollment in Pivotal Phase 3 LIBRA Trial..
6/07/2023	18:21	DJN	ADRs End Mostly Lower, Oatly and LianBio Trade Actively
6/06/2023	16:05	GLOBE	LianBio Announces Topline Results from Phase 2a Proof of..
6/01/2023	16:15	GLOBE	LianBio to Participate in Upcoming Investor Conferences